Current treatment options for asthma in adults

Area of Science:

• Pulmonology
• Allergy and Immunology
• Pharmacology

Background:

• Asthma prevalence is rising globally, posing significant health and economic burdens.
• Uncontrolled asthma is common, often due to patient underestimation of severity and lack of education on proper therapy.
• Current patient and physician understanding of asthma management needs improvement to address daily limitations and medication overuse.

Purpose of the Study:

• To emphasize the critical role of patient education in achieving optimal asthma control.
• To highlight the importance of differentiating asthma types for personalized treatment strategies.
• To review current therapeutic options and advances in asthma management.

Main Methods:

• Review of current asthma guidelines and treatment options.
• Discussion of pathophysiology and advances in asthma understanding over the past three decades.
• Emphasis on patient education and adherence to controller medications.

Main Results:

• Short-acting beta-2 agonists are first-line for intermittent and exercise-induced asthma.
• Inhaled corticosteroids (ICS) are the mainstay for persistent asthma, with add-on therapies including long-acting beta-2 agonists, theophylline, and leukotriene modifiers.
• Omalizumab (anti-IgE therapy) shows promise for specific moderate to severe persistent asthma cases, contingent on cost reduction.

Conclusions:

• Comprehensive asthma management requires a well-educated patient and a tailored medical regimen.
• Adherence to established guidelines and appropriate medication selection are crucial for improving asthma control.
• Advances in understanding and treatment options offer potential to reduce asthma morbidity and mortality.